Stocks · Health care · Biological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc.

ARTV Clue Score30
United States Fiscal year ends December CIK 0001817241 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Fred Aslan
2 Nov 2026
Chief Executive Officer
Sell
62,178
$4.18
$259.97K
Subhashis Banerjee
2 Nov 2026
Chief Medical Officer
Sell
1,110
$4.18
$4.64K
Jennifer Bush
2 Nov 2026
COO, CLO, Compliance Officer
Sell
8,439
$4.18
$35.28K
Christopher Horan
2 Nov 2026
Chief Tech Operations Officer
Sell
10,423
$4.18
$43.58K
Fred Aslan
6 Oct 2026
Chief Executive Officer
Sold on a plan
23,463
$7.20
$168.88K
Fred Aslan
5 Oct 2026
Chief Executive Officer
Sell
61,696
$6.84
$421.83K
Subhashis Banerjee
5 Oct 2026
Chief Medical Officer
Sell
1,099
$6.84
$7.51K
Jennifer Bush
5 Oct 2026
COO, CLO, Compliance Officer
Sell
8,370
$6.84
$57.23K
Christopher Horan
5 Oct 2026
Chief Tech Operations Officer
Sell
10,340
$6.84
$70.70K
Fred Aslan
8 Sep 2026
Chief Executive Officer
Sold on a plan
23,429
$10.92
$255.75K
Fred Aslan
3 Sep 2026
Chief Executive Officer
Sell
61,888
$11.16
$690.39K
Subhashis Banerjee
3 Sep 2026
Chief Medical Officer
Sell
1,100
$11.16
$12.27K
Jennifer Bush
3 Sep 2026
COO, CLO, Compliance Officer
Sell
8,391
$11.16
$93.61K
Christopher Horan
3 Sep 2026
Chief Tech Operations Officer
Sell
10,366
$11.16
$115.64K
Subhashis Banerjee
27 Aug 2026
Chief Medical Officer
Sold after exercise
8,222
$12.01
$98.74K
Subhashis Banerjee
18 Aug 2026
Chief Medical Officer
Sold after exercise
429
$12.00
$5.15K
Ra Capital Management, L.p.
31 Jul 2026
Director
Buy indirect
24,944
$9.93
$247.69K
Ra Capital Management, L.p.
29 Jul 2026
Director
Buy indirect
20,824
$9.99
$208.03K
Ra Capital Management, L.p.
24 Jul 2026
Director
Buy indirect
41,319
$9.99
$412.78K
Ra Capital Management, L.p.
23 Jul 2026
Director
Buy indirect
59,880
$9.96
$596.40K
Ra Capital Management, L.p.
22 Jul 2026
Director
Buy indirect
84,124
$9.93
$835.35K
Ra Capital Management, L.p.
21 Jul 2026
Director
Buy indirect
120,582
$9.55
$1.15M
Ra Capital Management, L.p.
17 Jul 2026
Director
Buy indirect
7,882
$8.95
$70.54K
Ra Capital Management, L.p.
16 Jul 2026
Director
Buy indirect
152,472
$8.93
$1.36M
Ra Capital Management, L.p.
13 Jul 2026
Director
Buy indirect
6,552
$8.94
$58.57K
Ra Capital Management, L.p.
10 Jul 2026
Director
Buy indirect
15,102
$8.97
$135.46K
Ra Capital Management, L.p.
26 Jun 2026
Director
Buy indirect
1,876
$8.98
$16.85K
Ra Capital Management, L.p.
25 Jun 2026
Director
Buy indirect
31,000
$8.88
$275.28K
Ra Capital Management, L.p.
16 Jun 2026
Director
Buy indirect
124,893
$8.89
$1.11M
Ra Capital Management, L.p.
15 Jun 2026
Director
Buy indirect
15,414
$8.99
$138.57K
Ra Capital Management, L.p.
12 Jun 2026
Director
Buy indirect
391,019
$8.57
$3.35M
Ra Capital Management, L.p.
11 Jun 2026
Director
Buy indirect
548,580
$7.91
$4.34M
Ra Capital Management, L.p.
10 Jun 2026
Director
Buy indirect
103
$7.00
$721.00
Ra Capital Management, L.p.
9 Jun 2026
Director
Buy indirect
479,039
$6.91
$3.31M
Fred Aslan
19 May 2026
Chief Executive Officer
Sell
27,116
$9.01
$244.25K
Subhashis Banerjee
19 May 2026
Chief Medical Officer
Sell
7,037
$9.01
$63.39K
Jennifer Bush
19 May 2026
COO, CLO, Compliance Officer
Sell
8,790
$9.01
$79.18K
Christopher Horan
19 May 2026
Chief Tech Operations Officer
Sell
7,002
$9.01
$63.07K
Heather Raymon
19 May 2026
SVP, Research and Development
Sell
3,095
$9.01
$27.88K
Ra Capital Management, L.p.
11 May 2026
Director
Buy indirect
6,510,416
$11.52
$75.00M
GC Corp.
11 May 2026
10% owner
Buy indirect
347,222
$11.52
$4.00M
GC Corp.
11 May 2026
10% owner
Buy
1,085,069
$11.52
$12.50M
Fred Aslan
15 Dec 2025
President and CEO
Sold on a plan
3,187
$6.00
$19.12K
Fred Aslan
17 Nov 2025
President and CEO
Sold on a plan
6,375
$3.38
$21.52K
Fred Aslan
17 Oct 2025
President and CEO
Sold on a plan
25,500
$6.00
$153.00K
Fred Aslan
15 Aug 2025
President and CEO
Sold on a plan
25,500
$2.73
$69.58K
Yong-Jun Huh
22 Jul 2024
Director
Buy indirect
416,666
$12.00
$5.00M
Yong-Jun Huh
22 Jul 2024
Director
Buy indirect
1,666,666
$12.00
$20.00M
GC Corp.
22 Jul 2024
10% owner
Buy indirect
416,666
$12.00
$5.00M
GC Corp.
22 Jul 2024
10% owner
Buy
1,666,666
$12.00
$20.00M
venBio Global Strategic Fund III, L.P.
22 Jul 2024
10% owner
Buy
416,666
$12.00
$5.00M
5AM Partners VI, LLC
22 Jul 2024
10% owner
Buy indirect
833,333
$12.00
$10.00M
Ra Capital Management, L.p.
22 Jul 2024
Director
Buy indirect
688,326
$12.00
$8.26M
Ra Capital Management, L.p.
22 Jul 2024
Director
Buy indirect
7,645,007
$12.00
$91.74M

What was left out

Form 4 filings counted 103
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 2
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 12,059,136
History held since 22 Jul 2024